Darrell Sleep
Darrell Sleep is Chief Scientific Officer at Albumedix, Denmark.
False
Advertisement
Being (Bio)Better
August 7, 2017
Why stop at biosimilar when improvements can be made? Biobetters can be challenging to develop, but offer dual rewards: more effective medicines for patients and valuable intellectual property for the developer.
1 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
